logo

ALBERTDAVD vs BROOKS: Stock Comparison

ALBERT DAVID vs BROOKS LABUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

ALBERT DAVID is the larger company by market capitalisation. ALBERT DAVID shows a higher dividend yield and faster revenue growth, while BROOKS LAB shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALBERTDAVD leads 4; BROOKS leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALBERTDAVDBROOKS

Valuation lens

What price are you paying?

Market CapContext only
₹446 Cr
₹177 Cr
P/E RatioBROOKS has the lower reading
20.76x
8.22x ✓
P/B RatioALBERTDAVD has the lower reading
1.2x ✓
1.65x
EPSALBERTDAVD has the higher reading
₹39.53 ✓
₹-0.61
Book ValueContext only
₹686.04
₹41.64
Dividend YieldALBERTDAVD has the higher reading
0.63% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ALBERTDAVD is the larger company
₹446 Cr vs ₹177 Cr
P/E Ratio
BROOKS has a lower P/E
8.22x vs 20.76x
P/B Ratio
ALBERTDAVD has a lower P/B
1.2x vs 1.65x
EPS
ALBERTDAVD has higher earnings per share
₹39.53 vs ₹-0.61
Dividend Yield
ALBERTDAVD has a higher dividend yield
0.63% vs 0%
Revenue Growth (TTM YoY)
ALBERTDAVD has faster revenue growth
14.6% vs -6.37%
ROE
BROOKS has a higher ROE
4.8% vs -0.38%
ROCE
BROOKS has a higher ROCE
5.46% vs 0.75%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDBROOKS
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDBROOKS
Live Price₹784.3₹61.09
Day Change2.01%0.51%
Volume3,80754,438
52-Week High₹931.85₹123.54
52-Week Low₹579.9₹36.3
Distance from 52W High-15.83%-50.55%

Valuation

MetricALBERTDAVDBROOKS
Market Cap₹446 Cr₹177 Cr
P/E Ratio20.76x8.22x
P/B Ratio1.2x1.65x
EPS₹39.53₹-0.61
Book Value₹686.04₹41.64
Dividend Yield0.63%0%

Growth

MetricALBERTDAVDBROOKS
Revenue Growth (TTM YoY)14.6%-6.37%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricALBERTDAVDBROOKS
ROE-0.38%4.8%
ROCE0.75%5.46%
Net Margin-0.45%28.67%
Operating Margin0.95%7.74%
Debt to Equity0.07x0.06x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricALBERTDAVDBROOKS
Promoter Holding62.24%52.62%
FII Holding0.6%▲ 0.03 pp0%▼ 0.17 pp
DII Holding1.64%10.38%
Public Holding35.53%▼ 0.03 pp37%▲ 0.16 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALBERT DAVID and BROOKS LAB.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.